Abidia A, Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, Masson EA, McCollum PT, et al.
European journal of vascular and endovascular surgery : the official journal of the European So.... Date of publication 2003 Jun 1;volume 25(6):513-8.
1. Eur J Vasc Endovasc Surg. 2003 Jun;25(6):513-8.
The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity
ulcers: a double-blind randomised-controlled trial.
Abidia A(1), Laden G, Kuhan G, Johnson BF, Wilkinson AR, Renwick PM, Masson EA,
McCollum PT.
Author information:
(1)Academic Surgical Unit, University of Hull and Hull Royal Infirmary, Hull,
U.K.
Comment in
Eur J Vasc Endovasc Surg. 2004 Jan;27(1):108.
OBJECTIVE: ischaemic lower-extremity ulcers in the diabetic population are a
source of major concern because of the associated high risk of limb-threatening
complications. The aim of this study was to evaluate the role of hyperbaric
oxygen in the management of these ulcers.
METHOD: eighteen diabetic patients with ischaemic, non-healing lower-extremity
ulcers were recruited in a double-blind study. Patients were randomly assigned
either to receive 100% oxygen (treatment group) or air (control group), at 2.4
atmospheres of absolute pressure for 90 min daily (total of 30 treatments).
RESULTS: healing with complete epithelialisation was achieved in five out of
eight ulcers in the treatment group compared to one out of eight ulcers in the
control group. The median decrease of the wound areas in the treatment group was
100% and in the control group was 52% (p=0.027). Cost-effectiveness analysis has
shown that despite the extra cost involved in using hyperbaric oxygen, there was
a potential saving in the total cost of treatment for each patient during the
study.
CONCLUSION: hyperbaric oxygen enhanced the healing of ischaemic, non-healing
diabetic leg ulcers and may be used as a valuable adjunct to conventional therapy
when reconstructive surgery is not possible.
DOI: 10.1053/ejvs.2002.1911
PMID: 12787692 [Indexed for MEDLINE]
